# Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

> **NCT01132547** · PHASE3 · TERMINATED · sponsor: **University of South Florida** · enrollment: 22 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** cyproheptadine hydrochloride
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01132547
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** The study was terminated due to slow accrual.
- **Last updated:** 2015-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01132547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01132547, "Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01132547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*